Evidence-based medicine (EBM) in practice: Understanding tests of heterogeneity in metaanalysis

American Journal of Gastroenterology

Volumn 100, Issue 6, 2005, Pages 1221-1223

  Schoenfeld, Philip S ^a,c   Loftus Jr , Edward V ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c VACM III D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; PLACEBO; PREDNISONE;

ADULT; ANEMIA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; META ANALYSIS; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; TERMINOLOGY;

EID: 21344469247     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50452.x     Document Type: Article

References (7)

1. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-41.
2. Pearson DC, May GR, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis. Ann Intern Med 1995;122:132-42.
3. Schoenfeld P, Cook D, Hamilton S, et al. An evidence-based approach to gastroenterology therapy. Gastroenterology 1999;116:1230-37.
4. Oxman AD, Cook DJ, Guyatt G. for the Evidence Based Medicine Working Group. Users' guide to the medical literature. VI. How to use an overview. JAMA 1994;272:1367-71.
5. Norgard B, Pedersen L, Fonanger K, et al. Azathioprine, mercaptopurine and birth outcome: A population-based study. Aliment Pharmacol Ther 2003;17:827-34.
6. Markowitz J, Grancher K, Kohn N, et al. for the Pediatric 6MP Collaborative Group. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
7. Akobeng AK, Gardener E. Cochrane Inflammatory Bowel Disease Group. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2005, 1.